Total Funding
95
64
Total FundingSeries C raised
Growth Score
5 pts
Heat Score
-25 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Events
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
2620
Science is a clinical-stage medical technology company that develops neuroengineering systems to address neurological and sensory disorders.
Max Hodak: Founder and CEOPast Role: Neuralink, Cofounder & President- Tricia Gugler: Chief Financial OfficerPast Role: ThirdLove, Vice President
About the Company
Science is a clinical-stage medical technology company focused on developing neural interface systems to address conditions such as vision loss, cognitive impairment, and motor dysfunction. The company integrates neural recording electronics, optogenetic stimulation, and software platforms to create brain-computer interface (BCI) solutions. Its
product suite includes Axon neural probes, the SciFi headstage, and the Synapse communication protocol, which together form a modular platform for neural engineering applications. Science also develops implantable devices like PRIMA, a wireless photovoltaic stimulation array aimed at restoring vision in patients with retinal degenerative diseases.
